Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ

$28.14

+$0.70 (2.55%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$26.89$28.45

Open $27.66

52 Week Range

$22.24$46.00

Previous Close $27.44

Market Cap1.67B

Volume1.27M

Avg Volume1.03M

P/E (TTM)-4.00

EPS (TTM)$-7.19

Dividend / YieldN/A

Dividend StreakN/A

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.

Company Info

SectorHealthcare

IndustryBiotechnology

CEOBrian Goff

Employees486

Websitewww.agios.com

Trading Information

Open

$27.66

Previous Close

$27.44

Day High

$28.45

Day Low

$26.89

52 Week High

$46.00

52 Week Low

$22.24